Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Newer agents in the treatment of multiple sclerosis.
Pawate S, Bagnato F. Pawate S, et al. Among authors: bagnato f. Neurologist. 2015 Apr;19(4):104-17. doi: 10.1097/NRL.0000000000000020. Neurologist. 2015. PMID: 25888198 Review.
Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.
Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S. Gelfand JM, et al. Among authors: bagnato f. Neurology. 2017 Nov 14;89(20):2092-2100. doi: 10.1212/WNL.0000000000004644. Epub 2017 Oct 13. Neurology. 2017. PMID: 29030454 Free PMC article.
Alemtuzumab for the treatment of multiple sclerosis.
Evan JR, Bozkurt SB, Thomas NC, Bagnato F. Evan JR, et al. Among authors: bagnato f. Expert Opin Biol Ther. 2018 Mar;18(3):323-334. doi: 10.1080/14712598.2018.1425388. Expert Opin Biol Ther. 2018. PMID: 29309202 Review.
131 results